These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Studies on the dissociation of tissue factor (tissue thromboplastin) on treatment with butan-1-ol. Muthe AV; Desai CS; Kale NR Biochem J; 1972 Jun; 128(1):47P. PubMed ID: 5085616 [No Abstract] [Full Text] [Related]
64. Spontaneous Increase in Potency of Thromboplastin From Acetone-extracted Brain Tissue. Aggeler PM; Leake TB; Talbot JC Science; 1948 Nov; 108(2810):507-9. PubMed ID: 17808929 [No Abstract] [Full Text] [Related]
65. The degeneration of brain thromboplastin in the presence of normal serum. BERRY CG J Clin Pathol; 1957 Nov; 10(4):342-5. PubMed ID: 13481118 [No Abstract] [Full Text] [Related]
66. Ontogenesis of brain thromboplastin and of encephalitogenic substance. SVET-MOLDAVSKY GJ; KRIEGSHABER MR Nature; 1963 Jan; 197():297. PubMed ID: 13979559 [No Abstract] [Full Text] [Related]
67. Circulating tissue factor in humans. Butenas S Pol Arch Med Wewn; 2016 May; 126(5):307-8. PubMed ID: 27243338 [No Abstract] [Full Text] [Related]
69. Activation of Thromboplastin Preparations by Haemolysis and by Lecithin. Crosbie A; Scarborough H Br Med J; 1941 Feb; 1(4181):268-71. PubMed ID: 20783536 [No Abstract] [Full Text] [Related]
70. [The participation of phospholipids in blood coagulation]. Zítko M Cesk Fysiol; 1979; 28(4):319-32. PubMed ID: 389461 [No Abstract] [Full Text] [Related]
71. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
72. Thrombomodulin activity is found in tissue thromboplastin preparations from placenta and from lung but not from brain. Freyssinet JM; Gauchy J; Spaethe R; Cazenave JP Haemostasis; 1987; 17(3):114-20. PubMed ID: 3038709 [TBL] [Abstract][Full Text] [Related]
73. Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity. Freyssinet JM; Brami B; Gauchy J; Cazenave JP Thromb Haemost; 1986 Feb; 55(1):112-8. PubMed ID: 3010487 [TBL] [Abstract][Full Text] [Related]
74. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563 [TBL] [Abstract][Full Text] [Related]
75. Thrombomodulin activity in commercial thromboplastin preparations. van Wijngaarden A; van den Besselaar AM; Bertina RM Thromb Res; 1986 Aug; 43(3):265-74. PubMed ID: 3016943 [TBL] [Abstract][Full Text] [Related]
76. The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. Freyssinet JM; Gauchy J; Cazenave JP Biochem J; 1986 Aug; 238(1):151-7. PubMed ID: 3026338 [TBL] [Abstract][Full Text] [Related]